Prostate Cancer: Screening
The question
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the impact on patient outcomes in (a)Newcastle-under-Lyme, (b) Staffordshire and (c) England of introducing a screening programme for prostate cancer.
Answered by Andrew Gwynne
Screening for prostate cancer is currently not recommended by the UK National Screening Committees (UK NSC). This is because of the inaccuracy of the current best test, the Prostate Specific Antigen (PSA). A PSA-based screening programme could harm men, as some of them would be diagnosed with a cancer that would not have caused them problems during their life. This would lead to additional tests and treatments which can also have harmful side effects, for example incontinence of faeces and urine, and impotence.
The UK NSC is undertaking an evidence review for prostate cancer screening and plans to report within the UK NSC’s three-year work plan. The evidence review includes modelling the clinical cost effectiveness of several approaches to prostate cancer screening, including different potential ways of screening the whole population from 40 years of age onwards and targeted screening aimed at groups of people identified as being at higher-than-average risk, such as black men or men with a family history of cancer.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →